
Zura Bio's skin disease drug fails mid-stage trial
来源:Reuters发布于 2026-11-09
Zura Bio said on Monday its experimental drug failed the main goal of a mid-stage study in patients with hidradenitis suppurativa, a chronic skin disease that causes painful lumps under the skin.
相关标的:ZURA
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。